Invesco Ltd. - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 129 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$85,508
-12.4%
63,812
+17.0%
0.00%
Q2 2023$97,629
-41.9%
54,541
+26.2%
0.00%
Q1 2023$168,161
+36.9%
43,229
+19.7%
0.00%
Q4 2022$122,829
-35.7%
36,126
+3.5%
0.00%
Q3 2022$191,000
+35.5%
34,901
+12.2%
0.00%
Q2 2022$141,000
-39.2%
31,095
-1.4%
0.00%
Q1 2022$232,000
+14.3%
31,546
-0.1%
0.00%
Q4 2021$203,000
+2.0%
31,568
-7.6%
0.00%
Q3 2021$199,000
-32.5%
34,157
+19.4%
0.00%
Q2 2021$295,000
+54.5%
28,606
+57.3%
0.00%
Q1 2021$191,000
-50.4%
18,180
-26.8%
0.00%
Q4 2020$385,000
+79.1%
24,830
+69.2%
0.00%
Q3 2020$215,000
-23.5%
14,678
-1.1%
0.00%
Q2 2020$281,000
-82.6%
14,837
-82.3%
0.00%
-100.0%
Q1 2020$1,614,000
-64.1%
84,039
-64.2%
0.00%0.0%
Q4 2019$4,498,000
+67.4%
234,619
-16.0%
0.00%0.0%
Q3 2019$2,687,000
+53640.0%
279,365
+143164.1%
0.00%
Q2 2015$5,0001950.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Delphi Management Partners VIII, L.L.C. 2,263,006$35,031,00023.03%
Palo Alto Investors LP 5,267,652$81,543,0004.28%
Fairmount Funds Management LLC 702,351$10,872,0003.89%
Birchview Capital, LP 188,000$2,910,0001.68%
Mesirow Financial Investment Management, Inc. 22,303$345,250,0001.09%
EMERALD ADVISERS, LLC 1,822,781$28,217,0000.94%
EMERALD MUTUAL FUND ADVISERS TRUST 1,661,236$25,716,0000.90%
RICE HALL JAMES & ASSOCIATES, LLC 1,552,504$24,033,0000.85%
Altium Capital Management LP 133,951$2,074,0000.77%
Hood River Capital Management LLC 931,754$14,424,0000.48%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders